ArticleFrontiers in nutrition2026
Insulin resistance and uric acid-related metabolic disturbances jointly identify individuals at high risk of advanced cardiovascular-kidney-metabolic syndrome: a population-based study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular-kidney-metabolic (CKM) syndrome encompasses metabolic abnormalities, chronic kidney disease, and cardiovascular disease. The triglyceride-glucose (TyG) index reflects insulin resistance-related glucose-lipid imbalance, whereas serum uric acid (SUA) reflects purine metabolism and renal urate handling. However, their independent and joint associations with advanced CKM remain unclear. Methods: We conducted a cross-sectional analysis of 8,939 adults from the Hakka Biobank baseline survey. Advanced CKM (stages 3-4) was defined according to the American Heart Association framework. Multivariable logistic regression examined associations of TyG and SUA with advanced CKM. Restricted cubic splines assessed nonlinearity, and joint associations used the same-dataset ROC-derived TyG threshold of 8.89 and sex-specific hyperuricemia (HUA) thresholds. Sensitivity and subgroup analyses assessed robustness and heterogeneity, while AUC and continuous net reclassification improvement (NRI) evaluated in-sample model performance. Results: Among 8,939 participants, 1,164 had advanced CKM. After adjustment, each 1-unit increase in TyG was associated with greater odds of advanced CKM (OR, 1.81; 95% CI, 1.64-2.01), as was each standard deviation increase in SUA (OR, 1.38; 95% CI, 1.28-1.48). TyG showed an approximately linear positive relationship, whereas SUA showed a J-shaped relationship ( Conclusion: Higher TyG and SUA levels, particularly their co-occurrence, were associated with prevalent advanced CKM. These biomarkers may characterize distinct but overlapping metabolic profiles relevant to CKM assessment. Their potential value for community-based evaluation requires confirmation in prospective studies with external validation; no causal or treatment implications can be inferred from these cross-sectional findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.